Synthesis, anti-bacterial and anti-fungal activities of some novel Schiff bases containing 2,4-disubstituted thiazole ring

European Journal of Medicinal Chemistry
S K BhartiS K Singh

Abstract

A series of arylidene-2-(4-(4-methoxy/bromophenyl) thiazol-2-yl) hydrazines (4a-z) and 1-(4-(4-methoxy/bromophenyl) thiazol-2-yl)-2-cyclohexylidene/cyclopentylidene hydrazines (5a-b/6a-b) were synthesized, characterized and screened for their antimicrobial activities. The structures of synthesized compounds were established by spectroscopic (FT-IR, (1)H NMR, (13)C NMR, Mass) and elemental analyses. Both the anti-bacterial and anti-fungal activities with MIC values of compounds were evaluated. The results of anti-bacterial screening reveal that among all the compounds screened eight compounds showed moderate to good anti-bacterial activity while ten of the newly synthesized compounds displayed good to excellent anti-fungal activity. Among the tested compounds, the most effective compounds with MIC value in the range of 6.25-25 microg/ml are 4a, 4n, 4z, 5a, 5b, 6a and 6b against three fungal strains viz. Candida albicans, Cryptococcus neoformans and Aspergillus flavus.

References

Jul 20, 1992·Journal of Medicinal Chemistry·W C PattB A Steinbaugh
Aug 1, 1996·Letters in Applied Microbiology·A M Revol-JunellesG Lefebvre
Sep 7, 1999·Bioorganic & Medicinal Chemistry Letters·J L BuchananD A Holt
Jun 16, 2000·International Journal of Antimicrobial Agents·M L MackayI M Gould
Jul 25, 2000·European Journal of Medicinal Chemistry·G Turan-ZitouniK Erol
Mar 23, 2001·Journal of Medicinal Chemistry·J E van Muijlwijk-KoezenA P IJzerman
Apr 2, 2003·European Journal of Medicinal Chemistry·B Shivarama HollaN Suchetha Kumari
Nov 28, 2006·European Journal of Medicinal Chemistry·Ahmet OzdemirKiymet Güven
Jun 2, 2007·European Journal of Medicinal Chemistry·Prakash KaregoudarNalilu Sucheta Kumari
Oct 27, 2007·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hamid Latif SiddiquiW Weaver
Nov 1, 1984·Immunology Today·H Metzger

❮ Previous
Next ❯

Citations

May 25, 2013·European Journal of Medicinal Chemistry·Simone CarradoriBruna Bizzarri
Jul 15, 2011·Acta Crystallographica. Section E, Structure Reports Online·Mohammad AsadHoong-Kun Fun
Aug 13, 2011·Acta Crystallographica. Section E, Structure Reports Online·Mohammad AsadHoong-Kun Fun
Aug 8, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Syahrul ImranSaima Tauseef
Sep 24, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Cristina NastasăOvidiu Oniga
Aug 16, 2015·European Journal of Medicinal Chemistry·Nívea Pereira de SáSusana Johann
Jun 2, 2012·Journal of Enzyme Inhibition and Medicinal Chemistry·Leyla YurttaşHülya Karaca
May 20, 2016·Journal of Enzyme Inhibition and Medicinal Chemistry·Krzysztof Z ŁączkowskiAnna Malm
May 10, 2017·Chemico-biological Interactions·Luiz Nascimento de Araújo NetoFrancisco Jaime Bezerra Mendonça-Junior
Apr 25, 2017·Acta Crystallographica. Section E, Crystallographic Communications·Huma BanoSammer Yousuf
Oct 30, 2013·Antimicrobial Agents and Chemotherapy·Edna de Farias SantiagoAna Cristina Lima Leite
Jul 27, 2010·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rafat M Mohareb, Abeer A Mohamed
Aug 17, 2018·Mini Reviews in Medicinal Chemistry·Swarnagowri Nayak, Santhosh L Gaonkar
Dec 26, 2018·Anti-cancer Agents in Medicinal Chemistry·Hany A M El-SheriefHamdy M Abdel-Rahman
Dec 3, 2014·Chemical & Pharmaceutical Bulletin·Mohammad Sayed AlamDong-Ung Lee
Dec 9, 2014·Acta Crystallographica. Section E, Structure Reports Online·Bhimashankar M HalasangiG N Anil Kumar
Dec 14, 2018·Journal of Fungi·Lana Ivone Barreto CruzSusana Johann
Aug 17, 2019·Acta Crystallographica. Section E, Crystallographic Communications·Trung Vu QuocLuc Van Meervelt
May 12, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mohammed A Al-OmairMagdy M Youssef
Jan 13, 2016·Molecular Diversity·Fateme Ghanbari Pirbasti, Nosrat O Mahmoodi
Jul 23, 2020·Acta Crystallographica. Section E, Crystallographic Communications·Ropak A Sheakh MohamadWali M Hamad
Jun 19, 2014·Acta Crystallographica. Section E, Structure Reports Online·Shaaban K MohamedMustafa R Albayati
Apr 16, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hui LuLinhong Jin
Feb 5, 2021·Journal of Biomolecular Structure & Dynamics·Shankar G AlegaonSunil S Jalalpure
Mar 20, 2021·Probiotics and Antimicrobial Proteins·Konstantin A DeminMichael L Chikindas
Oct 5, 2010·Bioorganic & Medicinal Chemistry Letters·Hai-Bo ShiWei-Xiao Hu
Aug 27, 2021·European Journal of Medicinal Chemistry·Vivek AsatiG D Gupta
Jan 1, 2013·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Mustafa ŞahinUğur Arslan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.